Literature DB >> 9576219

Operative approach for multiple primary lung carcinomas.

M Okada1, N Tsubota, M Yoshimura, Y Miyamoto.   

Abstract

Of 908 patients who underwent operation for primary lung cancer between January 1985 and June 1996, we considered 57 (6.3%) to have a second primary lung cancer, which was synchronous in 28 cases (3.1%) and metachronous in 29 cases (3.2%). Five-year survival for patients with synchronous and metachronous disease from initial treatment of cancer was 70.3% and 66.0%, respectively. Survival after the development of a metachronous lesion was 32.9% at 5 years. Sixteen of the synchronous second tumors (57%) were detected on preoperative radiography or bronchoscopy and 11 (39%) at the time of operation. Survival of patients at stage I or II from treatment of a synchronous lesion (p = 0.002) and of a metachronous second lesion (p = 0.028) was significantly better compared with those at stage III or IV. Therefore it is important to carefully examine a synchronous lesion before and during the operation of a primary lung cancer and to perform close follow-up surveillance for early detection of a metachronous lesion. In treating multiple lung carcinomas consideration should always be given to performing precise staging, aggressive operative approach for early stage, and oncologically sound parenchymal sparing procedures.

Entities:  

Mesh:

Year:  1998        PMID: 9576219     DOI: 10.1016/S0022-5223(98)70364-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  20 in total

Review 1.  Microsatellite alteration in multiple primary lung cancer.

Authors:  Cheng Shen; Xin Wang; Long Tian; Guowei Che
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Clinical features of multiple lung cancers based on thin-section computed tomography: what are the appropriate surgical strategies for second lung cancers?

Authors:  Aritoshi Hattori; Kenji Suzuki; Kazuya Takamochi; Shiaki Oh
Journal:  Surg Today       Date:  2014-05-22       Impact factor: 2.549

3.  Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.

Authors:  Stephen J Murphy; Marie-Christine Aubry; Faye R Harris; Geoffrey C Halling; Sarah H Johnson; Simone Terra; Travis M Drucker; Michael K Asiedu; Benjamin R Kipp; Eunhee S Yi; Tobias Peikert; Ping Yang; George Vasmatzis; Dennis A Wigle
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

Review 4.  Surgical treatment for early stage non-small cell lung cancer.

Authors:  Vignesh Raman; Chi-Fu Jeffrey Yang; John Z Deng; Thomas A D'Amico
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

5.  Surgical treatment for chronic pleural empyema.

Authors:  M Okada; N Tsubota; M Yoshimura; Y Miyamoto; H Yamagishi; S Satake
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Outcomes of Sleeve Lobectomy versus Pneumonectomy for Lung Cancer.

Authors:  Hong-Kyu Lee; Hee-Sung Lee; Kun-Il Kim; Ho-Seung Shin; Jae-Woong Lee; Hyoung-Soo Kim; Sung-Woo Cho
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-12-07

7.  Surgical resection of recurrent lung cancer in patients following curative resection.

Authors:  Hyoung Soo Kim; Hoseok I; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim; Jhingook Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

8.  For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy?

Authors:  Qian-Li Ma; Yong-Qing Guo; Bin Shi; Yan-Chu Tian; Zhi-Yi Song; De-Ruo Liu
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

9.  Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis.

Authors:  Mark K Farrugia; Sung Jun Ma; Mark W Hennon; Chukwumere E Nwogu; Elisabeth U Dexter; Anthony L Picone; Todd L Demmy; Jorge A Gomez-Suescun; Simon Fung-Kee-Fung; Sai S Yendamuri; Anurag K Singh
Journal:  Am J Clin Oncol       Date:  2021-01-01       Impact factor: 2.339

10.  Long-term results of curative intraluminal high dose rate brachytherapy for endobronchial carcinoma.

Authors:  Hidemasa Kawamura; Takeshi Ebara; Hiroyuki Katoh; Tomoaki Tamaki; Hitoshi Ishikawa; Hideyuki Sakurai; Takashi Nakano
Journal:  Radiat Oncol       Date:  2012-07-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.